Latest AI and machine learning research in hemophilia for healthcare professionals.
BACKGROUND: Edoxaban is a specific anti-Xa inhibitor that, in comparison to warfarin, has been found...
PURPOSE: We investigate the safety and efficacy of pharmacological venous thromboembolism prophylaxi...
Anthrax is a highly lethal, acute infectious disease caused by the rod-shaped, Gram-positive bacteri...
BACKGROUND: Sivelestat is a neutrophil elastase inhibitor (NEI) with positive impact on the respirat...
BACKGROUND: We report our experience dosing and monitoring enoxaparin with anti-factor Xa activity (...
The aim of the present study was to ascertain the effect of Porphyromonas gingivalis cysteine protea...
Hypertension has a major associated risk for organ damage and mortality, which is further heightened...
Anastrozole is an aromatase inhibitor (AI) used as adjuvant therapy for breast cancer. Anastrozole i...
OBJECTIVE: Third-generation aromatase inhibitors (AI) are potent suppressors of aromatase activity. ...
BACKGROUND: Crizotinib, an ATP-competitive receptor tyrosine kinase inhibitor of both anaplastic lym...
Fingolimod is an immunosuppressive agent which is used for the prophylaxis of organ transplantation ...
Background.Renoprotective therapies - SGLT2 inhibitors, finerenone, and renin-angiotensin system inh...
Liver sinusoidal endothelial cells (LSECs) are increasingly recognized as a critical yet underexplor...
Treatment of advanced head and neck squamous cell carcinoma (HNSCC) often involves radiotherapy comb...
Cancer cells display heterogeneous pathway activity that shapes therapeutic vulnerability, but mappi...
A key question in cell biology is how cell-scale organization emerges from a given set of molecular ...
The ABACUS study was a single arm, phase II trial evaluating neoadjuvant atezolizumab in operable ur...
Second generation antiandrogens, such as enzalutamide, are commonly prescribed to treat advanced pro...
Metabolic dysfunction is increasingly recognized as a risk factor for poor outcomes in breast cancer...
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can cause ser...
Rational design of covalent inhibitors requires simultaneously optimizing multiple properties, such ...